AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 27, 1998
REGISTRATION NO. 333-57119
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
_______________
INCYTE PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware 94-3136539
(State or other jurisdiction of
incorporation or organization) (I.R.S.Employer Identification No.)
3174 Porter Drive
Palo Alto, California 94304
(650) 855-0555
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
ROY A. WHITFIELD
Chief Executive Officer
Incyte Pharmaceuticals, Inc.
3174 Porter Drive
Palo Alto, California 94304
(650) 855-0555
(Name, address, including zip code, and telephone number, including area
code, of agent for service)
Copies to:
STANTON D. WONG
SALLY BRAMMELL
Pillsbury Madison & Sutro LLP
P.O. Box 7880
San Francisco, California 94120
_______________
<PAGE>
TERMINATION OF REGISTRATION
Incyte Pharmaceuticals, Inc. (the "Registrant") hereby removes and withdraws
from registration 922,987 shares of Common Stock, $.001 par value, of the
Registrant. The Shares were unsold at the termination of the offering covered
by this Registration Statement.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form
S-3 and has duly caused this Post-Effective Amendment No. 1 to be signed on
its behalf by the undersigned, thereunto duly authorized in the City of Palo
Alto, State of California, on October 27, 1998.
INCYTE PHARMACEUTICALS, INC.
By /s/ Denise M. Gilbert
---------------------
Denise M. Gilbert
Executive Vice President
and CFO
Pursuant to the requirements of the Securities Act, this Post-Effective
Amendment No. 1 to the Registration Statement has been signed below by the
following persons in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
<S> <C> <C>
Name Title Date
- - --------------------- ------------------------------- ----------------
Chief Executive Officer October 27, 1998
* (Principal Executive Officer)
- - --------------------- and Director
Roy A. Whitfield
Executive Vice President and October 27, 1998
* Chief Financial Officer
- - --------------------- (Principal Financial Officer)
Denise M. Gilbert
Controller
* (Principal Accounting Officer) October 27, 1998
- - ---------------------
William Delaney
* Chairman of the Board October 27, 1998
- - ---------------------
Jeffrey J. Collinson
* Director October 27, 1998
- - ---------------------
Barry M. Bloom
October 27, 1998
* Director
- - ---------------------
Frederick B. Craves
October 27, 1998
* Director
- - ---------------------
Jon S. Saxe
October 27, 1998
* Director
- - ---------------------
Randal W. Scott
</TABLE>
* By: /s/ Denise M. Gilbert
------------------------
Denise M. Gilbert
Attorney-in-Fact
